Journal Article
Dispersion of Repolarisation and the Autonomic System—Can We Predict Torsade de Pointes?
Heikki Huikuri
Cardiovascular Drugs and Therapy, 2002, Volume 16, Number 2, Pages 93-99
Journal Article
Effects of Adenosine A1-receptor activation on Torsade de Pointes in Rabbits
Hanno L. Tan, Charles J. Y. Hou and Ruey J. Sung
Cardiovascular Drugs and Therapy, 1999, Volume 13, Number 5, Pages 441-447
Journal Article
Reduced repolarization reserve due to anthracycline therapy facilitates torsade de pointes induced by IKr blockers
P. Milberg, D. Fleischer, J. Stypmann, N. Osada and G. Mönnig, et al.
Basic Research in Cardiology, 2007, Volume 102, Number 1, Pages 42-51
Journal Article
Clinical use of and future perspectives on antiarrhythmic drugs
Juan Carlos Estrada and Dawood Darbar
European Journal of Clinical Pharmacology, 2008, Volume 64, Number 12, Pages 1139-1146
Book Chapter
Mechanisms of Drug-Induced Cardiac Toxicity
Masayasu Hiraoka
2008, Electrical Diseases of the Heart, Part V, Pages 691-704
Book Chapter
Proarrhythmia
D.M. Roden and M.E. Anderson
Handbook of Experimental Pharmacology, 1, Volume 171, Basis and Treatment of Cardiac Arrhythmias, Pages 73-97
Journal Article
Preclinical cardio-safety assessment of torsadogenic risk and alternative methods to animal experimentation: The inseparable twins
B. M. Dumotier and A. V. Georgieva
Cell Biology and Toxicology, 2007, Volume 23, Number 4, Pages 293-302
Book Chapter
Antiarrhythmic Drug Management
Henry H. Hsia and Kelly Matsuda
2010, Critical Care Study Guide, Part 3, Pages 996-1025
Journal Article
Role of Dofetilide in Patients with Atrial Fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study
Steven N. Singh
Cardiac Electrophysiology Review, 2003, Volume 7, Number 3, Pages 225-228
Book Chapter
Pharmacogenomics in Drug Development
When and How to Apply
Richard Judson and Arthur J. Moss
2005, Cardiac Safety of Noncardiac Drugs, Part II, Pages 83-103